News

Zepbound beats Wegovy for weight loss in trial of blockbuster drugs
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
Everyday Health on MSN22h
Zebound Beats Wegovy for Weight Loss in First Head-to-Head Trial
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
MarketWatch19h
Here’s how much extra weight is lost with Zepbound over Wegovy
A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their waists compared with Novo Nordisk’s rival Wegovy. Barbara ...
The Citizen9h
Dick's Sporting Goods is buying struggling shoe chain Foot Locker for $2.4 billion
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head trial of the blockbus… The founder and former CEO of the cryptocurrency lending ...
The Indian Express23h
FTC vs Meta: Key moments from Mark Zuckerberg, Sheryl Sandberg testimonies in antitrust trial
A blockbuster antitrust trial featuring Meta kicked off in the US last week, with CEO Mark Zuckerberg taking the stand in court to defend the tech giant’s acquisitions of Instagram and WhatsApp over a ...